Feedback / Questions
Imfinzi (durvalumab) - AstraZeneca
Imjudo (tremelimumab-actl) - AstraZeneca
RBS2418 - Riboscience
http://clinicaltrials.gov/ct2/show/NCT07175441
Sep 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next